Lv41
436 积分 2025-10-07 加入
NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer (NCT02364557)
1小时前
求助中
The Clonal Evolution of Tumor Cell Populations
1小时前
已完结
Expression of HIF‐1α by human macrophages: implications for the use of macrophages in hypoxia‐regulated cancer gene therapy
1小时前
已完结
Clinical relevance of tumour-associated macrophages
1小时前
已完结
The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status
1小时前
已完结
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
1小时前
已完结
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future Focus
1小时前
已完结
Radiotherapy and immunotherapy: open questions and future strategies
1小时前
已完结
Network Analysis Identifies Regulators of Basal-Like Breast Cancer Reprogramming and Endocrine Therapy Vulnerability
1小时前
已完结
C/EBPα alleviates hepatic ischemia‐reperfusion injury by inhibiting endoplasmic reticulum stress via HDAC1‐mediated deacetylation of ATF4
1小时前
已完结
皖公网安备34019202002308
